Aurélien Lambert
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 38
- Pancreatic and Hepatic Oncology Research 28
- Colorectal Cancer Treatments and Studies 4
- COVID-19 and healthcare impacts 4
-
- Artificial Intelligence in Healthcare and Education 3
- Co-authors
- Thierry Conroy (17 shared papers)Michel Pierre Ducreux (11 shared papers)Lilian Schwarz (2 shared papers)Jean–Luc Van Laethem (2 shared papers)Ivan Borbath (2 shared papers)David Malka (1 shared paper)Céline Gavoille (5 shared papers)Jean‐Luc Van Laethem (1 shared paper)
In The Last Decade
Aurélien Lambert
46 papers receiving 880 citations
Aurélien Lambert's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 657
- Cancer Research 59
- Biomaterials 33
- Health Informatics 6
- Immunology 35
Countries citing papers authored by Aurélien Lambert
This map shows the geographic impact of Aurélien Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Lambert more than expected).
Fields of papers citing papers by Aurélien Lambert
This network shows the impact of papers produced by Aurélien Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Lambert. The network helps show where Aurélien Lambert may publish in the future.
Co-authors
The 25 scholars most cited alongside Aurélien Lambert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Hit paper breakdown → | 2022 | 225 |
| 2 | 2019 | 173 | |
| 3 | 2016 | 154 | |
| 4 | 2017 | 49 | |
| 5 | 2024 | 39 | |
| 6 | 2021 | 34 | |
| 7 | 2023 | 23 | |
| 8 | 2022 | 22 | |
| 9 | 2024 | 21 | |
| 10 | 2017 | 20 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 13 | |
| 13 | 2024 | 9 | |
| 14 | 2018 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2020 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2023 | 6 |
About Aurélien Lambert
Aurélien Lambert is a scholar working on Oncology, Health Informatics, Cancer Research, Cardiology and Cardiovascular Medicine and Otorhinolaryngology, having authored 59 papers that have together received 899 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (28 papers), Colorectal Cancer Treatments and Studies (4 papers), COVID-19 and healthcare impacts (4 papers), Cancer Genomics and Diagnostics (4 papers), Artificial Intelligence in Healthcare and Education (3 papers), Nutrition and Health in Aging (3 papers), Colorectal and Anal Carcinomas (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Oncology (657 citations), Cancer Research (59 citations), Biomaterials (33 citations), Health Informatics (6 citations) and Immunology (35 citations). Aurélien Lambert has collaborated with scholars based in France, Canada and Belgium. Frequent co-authors include Thierry Conroy, Michel Pierre Ducreux, Lilian Schwarz, Jean–Luc Van Laethem, Ivan Borbath, David Malka, Céline Gavoille, Jean‐Luc Van Laethem, F. Huguet and Ahmet Ayav. Their work appears in journals such as Annals of Oncology, Cancers, Journal of Clinical Oncology, European Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.